CN104491725B - A kind of Chinese medicine preparation for treating fatty liver and hyperlipidemia - Google Patents
A kind of Chinese medicine preparation for treating fatty liver and hyperlipidemia Download PDFInfo
- Publication number
- CN104491725B CN104491725B CN201410800220.2A CN201410800220A CN104491725B CN 104491725 B CN104491725 B CN 104491725B CN 201410800220 A CN201410800220 A CN 201410800220A CN 104491725 B CN104491725 B CN 104491725B
- Authority
- CN
- China
- Prior art keywords
- parts
- hyperlipidemia
- fatty liver
- chinese medicine
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a kind of Chinese medicine preparation for treating fatty liver and hyperlipidemia, and raw material includes following Chinese medicinal component：Curcuma zedoary, radix paeoniae rubra, hawthorn, gynostemma pentaphylla, Cassia occidentalis, giant knotweed, turmeric, Radix Astragali, matrimony vine.Provided by the present invention for treating the Chinese medicine preparation of fatty liver and hyperlipidemia, fatty liver and hyperlipidemia can be effectively treated, and cheap.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines more particularly to a kind of Chinese medicine systems for treating fatty liver and hyperlipidemia
Agent.
Background technology
Fatty liver is a kind of disease relatively conventional in modern diseases.The disease incidence up to 50% or so, and focus mostly in
30~60 years old males.Mild fatty liver is mostly without clinical symptoms.In, severe fatty liver have the performance of similar chronic hepatitis, can have
Loss of appetite, lassitude and weak, Nausea and vomiting, hepatic region or upper right abdomen secret anguish, if cannot effectively treat, to eventually result in liver hard
Change etc..Up to the present, Western medicine there is no lipotropic active drug；Hyperlipidemia is a kind of rich people's disease for perplexing modern,
It can increase the viscosity of blood, endanger blood circulation system and form vascular sclerosis.Hyperlipidemia can lead to coronary heart disease, hypertension.Most
Lead to diabetes, sudden death of heart disease, apoplexy etc. eventually.Though there is the drug in terms of some curers, effect is still very undesirable, and
There is different degrees of side effect, larger pain is brought to patient, and spend higher.
Invention content
It is an object of the invention to solve the problems of the above-mentioned prior art, it is good to provide a kind of using effect, cost compared with
The Chinese medicine preparation of low treatment fatty liver and hyperlipidemia.
A kind of Chinese medicine preparation for treating fatty liver and hyperlipidemia, raw material includes following Chinese medicinal component：It is curcuma zedoary, red
Chinese herbaceous peony, hawthorn, gynostemma pentaphylla, Cassia occidentalis, giant knotweed, turmeric, Radix Astragali, matrimony vine.
Further, the Chinese medicine preparation as described above for treating fatty liver and hyperlipidemia, raw material includes following
The traditional Chinese medicinal components of mass parts：15 parts -75 parts of curcuma zedoary, 12 parts -60 parts of radix paeoniae rubra, 12 parts -60 parts of hawthorn, 12 part -60 of gynostemma pentaphylla
Part, 12 parts -60 parts of Cassia occidentalis, 15 parts -75 parts of giant knotweed, 12 parts -60 parts of turmeric, 15 parts -75 parts of Radix Astragali, 15 part -75 of matrimony vine
Part.
Further, the Chinese medicine preparation as described above for treating fatty liver and hyperlipidemia, raw material includes following
The traditional Chinese medicinal components of mass parts：15 parts of curcuma zedoary, 12 parts of radix paeoniae rubra, 12 parts of hawthorn, 12 parts of gynostemma pentaphylla, 12 parts of Cassia occidentalis, 15 parts of giant knotweed, ginger
It is 12 parts yellow, 15 parts of Radix Astragali, 15 parts of matrimony vine.
Further, the Chinese medicine preparation as described above for treating fatty liver and hyperlipidemia, raw material includes following
The traditional Chinese medicinal components of mass parts：Choose 30 parts of curcuma zedoary, 24 parts of radix paeoniae rubra, 24 parts of hawthorn, 24 parts of gynostemma pentaphylla, 24 parts of Cassia occidentalis, giant knotweed 30
Part, 24 parts of turmeric, 30 parts of Radix Astragali, 30 parts of matrimony vine.
Further, the Chinese medicine preparation as described above for treating fatty liver and hyperlipidemia, raw material includes following
The traditional Chinese medicinal components of mass parts：Choose 75 parts of curcuma zedoary, 60 parts of radix paeoniae rubra, 60 parts of hawthorn, 60 parts of gynostemma pentaphylla, 60 parts of Cassia occidentalis, giant knotweed 75
Part, 60 parts of turmeric, 75 parts of Radix Astragali, 75 parts of matrimony vine.
Provided by the present invention for treating the Chinese medicine preparation of fatty liver and hyperlipidemia, fatty liver and height can be effectively treated
Pionemia, and it is cheap.
Specific implementation mode
To make the object, technical solutions and advantages of the present invention clearer, the technical solution below in the present invention carries out clear
Chu is fully described by, it is clear that described embodiments are some of the embodiments of the present invention, instead of all the embodiments.It is based on
Embodiment in the present invention, those of ordinary skill in the art are obtained every other without creative efforts
Embodiment shall fall within the protection scope of the present invention.
The treatment fatty liver of the present invention and the Chinese medicine preparation preparation method of hyperlipidemia are as follows：(1) 15 parts of curcuma zedoary-is chosen
75 parts, 12 parts -60 parts of radix paeoniae rubra, 12 parts -60 parts of hawthorn, 12 parts -60 parts of gynostemma pentaphylla, 12 parts -60 parts of Cassia occidentalis, giant knotweed 15
- 75 parts of part, 12 parts -60 parts of turmeric, 15 parts -75 parts of Radix Astragali, 15 parts -75 parts of matrimony vine；(2) nine traditional Chinese medicines of the above selection are taken
The water of 6-8 times of gross mass decocted, decoct three times, boil every time 40-50 minutes, filter and merge decoction liquor, will decoct
Liquid is concentrated into the inspissated juice that relative density is 1.15-1.30 (80 DEG C), then mass percent concentration is added at ambient temperature and is
95% ethyl alcohol, stirring while adding, the addition of the ethyl alcohol is 1.2-2 times of the gross mass of inspissated juice, and it is small then to place 24
When more than, extract supernatant, the ethyl alcohol in supernatant is recycled, gives back to and sweetener is added in the supernatant for harvest ethyl alcohol,
The pH value for adjusting solution is 5.0-7.0, and finally plus water is sufficiently mixed with supernatant, stirs evenly standing, and through filtered, sterilizing is filling
Preparation can be completed.
Embodiment one：
(1) 150 grams of curcuma zedoary, 120 grams of radix paeoniae rubra, 120 grams of hawthorn, 120 grams of gynostemma pentaphylla, 120 grams of Cassia occidentalis, giant knotweed 150 are chosen
Gram, 120 grams of turmeric, 150 grams of Radix Astragali, 150 grams of matrimony vine；(2) water of 6 times of the gross mass of the nine traditional Chinese medicines of the above selection is taken to carry out again
It decocts, decocts three times, boil every time 40 minutes, filter and merge decoction liquor, be concentrated into the concentration of relative density 1.15 (80 DEG C)
Juice, then the ethyl alcohol that the mass percent concentration of 1.2 times of inspissated juice gross mass is 95% is added at ambient temperature, side edged stirs
It mixes, then place 24 hours or more, supernatant is extracted, the ethyl alcohol in supernatant is recycled, then give back to the supernatant for harvesting ethyl alcohol
Middle that appropriate sweetener is added, the pH value for adjusting solution is 5.0, and finally plus water makes solution reach 10000ml, stirs evenly standing, passes through
Filtration, sterilizing are filling that preparation can be completed.
Embodiment two：
(1) 300 grams of curcuma zedoary, 240 grams of radix paeoniae rubra, 240 grams of hawthorn, 240 grams of gynostemma pentaphylla, 240 grams of Cassia occidentalis, giant knotweed 300 are chosen
Gram, 240 grams of turmeric, 300 grams of Radix Astragali, 300 grams of matrimony vine；(2) 7.2 times of weight of gross mass of the nine traditional Chinese medicines of the above selection are taken again
Water is decocted, and is decocted three times, is boiled every time 50 minutes, filter and merge decoction liquor, be concentrated into relative density 1.25 (80 DEG C)
Inspissated juice, then at ambient temperature be added inspissated juice gross mass be 1.6 times mass percent concentration be 95% ethyl alcohol,
It is stirring while adding, then place 24 hours or more, supernatant is extracted, the ethyl alcohol contained in supernatant is recycled, then give back to and harvest
Appropriate sweetener is added in the supernatant of ethyl alcohol, the pH value for adjusting solution is 6.0, and finally plus water makes solution reach 10000ml, stirs
Even standing, through filtered, sterilizing is filling that preparation can be completed.
Embodiment three：
(1) 750 grams of curcuma zedoary, 600 grams of radix paeoniae rubra, 600 grams of hawthorn, 600 grams of gynostemma pentaphylla, 600 grams of Cassia occidentalis, giant knotweed 750 are chosen
Gram, 600 grams of turmeric, 750 grams of Radix Astragali, 750 grams of matrimony vine；(2) water of 8 times of the gross mass of the nine traditional Chinese medicines of the above selection is taken to carry out again
It decocts, decocts three times, boil every time 45 minutes, filter and merge decoction liquor, be concentrated into the concentration of relative density 1.30 (80 DEG C)
Juice, then the ethyl alcohol that mass percent concentration that the gross mass of inspissated juice is 2 times is 95% is added at ambient temperature, side edged stirs
It mixes, then place 24 hours or more, supernatant is extracted, the ethyl alcohol contained in supernatant is recycled, then give back to and harvest the upper of ethyl alcohol
Appropriate sweetener is added in clear liquid, the pH value for adjusting solution is 7.0, and finally plus water makes solution reach 10000ml, stirs evenly standing,
Through filtered, sterilizing is filling that preparation can be completed.
Model case：
Name:So-and-so tall gender：Female's age：61 years old addresses：Xinxiang Ma little Ying
There is aphasia in patient, upper left myasthenia of limbs is admitted to hospital, with dizziness, palpitaition, difference of receiving.Human health screening, blood pressure 170/
100mmhg, sanity, aphasia, left center face tongue paralysis, white and greasy fur, Cervical Vessels are not heard and exception.Under upper left
4 grades of muscular strength, hypomyotonia, left side pathology sign are positive.Head CT shows that multiple cerebral, blood fat show total cholesterol 7.28mol/
L, triglyceride 2.19mol/L, high density cholesterol 1.22mol/L, low density cholesterol 4.70mol/L.Enter section's diagnosis：It is multiple
Property cerebral infarction, hyperlipidemia.It is routinely given to symptomatic treatments such as anti-bolt, improvement brain blood circulations after entering section, while adding and using mouth of the present invention
It takes liquid 20ml/ times, takes orally 3 times a day, blood fat is checked after 20 days and shows that 3.87mol/L, triglyceride 1.5mol/L, high density courage consolidate
Alcohol 1.92mol/L, low density cholesterol 2.28mol/L, is obviously improved when being relatively admitted to hospital, significant in efficacy, advises usually low fat diet, after
Continuous oral maintaining treatment.
Name:Yang's gender：The male age：58 years old addresses：The new electric cell in Xinxiang
There is burst dizziness in patient, and left side myasthenia of limbs is admitted to hospital, with dizziness, palpitaition, difference of receiving, existing coronary heart disease, atrial fibrillation disease
Official.Human health screening, blood pressure 150/90mmhg, sanity, spirit is poor, and speech is fluent, and tongue nature is slightly dark, white and greasy fur, neck blood
Guan Weiwen and exception.5 grades of muscular strength under upper left, hypomyotonia, left side pathology sign are positive.Head MRL shows multiple cerebral, blood
Fat shows total cholesterol 6.15mol/L, triglyceride 2.95mol/L, high density cholesterol 0.75mol/L, low density cholesterol
4.36mol/L.Enter section's diagnosis：Cerebral infarction, hyperlipidemia.It is routinely given to symptomatic treatments such as anti-bolt, improvement brain blood circulations after entering section,
Add use oral solution of the present invention simultaneously 20ml/ times, take orally 3 times a day, blood fat is checked after 20 days and shows 3.51mol/L, triglyceride
0.58mol/L, high density cholesterol 2.12mol/L, low density cholesterol 1.78mol/L are obviously improved when being relatively admitted to hospital, and curative effect is aobvious
It writes, advises usually low fat diet, continue oral maintaining treatment.
Name:So-and-so gender of Meng：Female's age：60 years old addresses：Xinxiang West Platform head
There is left limb hemiplegia 2 weeks in patient, and abdominal distension is received poor 10 days and is admitted to hospital, the past body obesity, 10 years high blood pressures
Official, human health screening, weight 80KG, blood pressure 164/102mmhg, sanity, spirit is poor, and aphasia, abdominal distension, appetite is fine,
No nausea is intended to spit, when feel nose heave, tongue nature is slightly dark, and tongue is greasy in vain, and stringy and hesitant pulse, neck is soft, 3 grades of muscular strength under upper right, and pathology sign in right side is negative.
Head MRL shows that multiple cerebral, encephalatrophy, blood fat show total cholesterol 8.12mol/L, triglyceride 5.26mol/L, high density
Cholesterol 0.79mol/L, low density cholesterol 5.53mol/L.Enter section's diagnosis：Cerebral infarction, hyperlipidemia.It is routinely given after entering section
Anti- bolt improves the symptomatic treatments such as brain blood circulation, while adding use oral solution of the present invention 20ml/ times, takes orally 3 times a day, multiple after 20 days
Fat of having a blood test shows 5.03mol/L, triglyceride 2.58mol/L, high density cholesterol 1.52mol/L, low density cholesterol
2.38mol/L is obviously improved when being relatively admitted to hospital, significant in efficacy, advises usually low fat diet, continues oral maintaining treatment.
Name：Slowly so-and-so gender：The male age：55 years old
There is dizzy, weak, right hypochondriac region discomfort in patient before last week, secret anguish gradually aggravates to be admitted to hospital, with loss of appetite, abdomen
It is swollen, belch, hepatic region turgor；Previously there is high blood pressure medical history 10 years；History of coronary heart disease 5 years.Physical examination, 160/95mmhg, mind is clear,
Spiritual poor, chronic face, auscultation of lung no abnormality seen, heart circle expand to left down, 70 beats/min of heart rate.A2>P2, abdominal distention, liver
Palpation of spleen owes satisfaction, and Murphy signs are negative, have no liver distension of jugular vein.Other are checked：Electrocardio illustrates：Deficiency myocardial blood supply surpasses
Sound prompts:Severe fatty liver；Chemically examine blood fat, total cholesterol 7.2mmol/L, triglyceride 4.8mmol/L, low-density lipoprotein
0.86mmol/L.Liver function：Glutamic-oxalacetic transaminease 51mmol/L, glutamic-pyruvic transaminase 78mmol/L, hepatitis B surface antigen (-) property surpass
Sound prompts:Severe fatty liver；Clinical diagnosis：1 fatty liver (severe) 2, hyperlipidemia 3,2 grade 4 of hypertension, coronary heart disease；Main application
Following therapy, reducing blood lipid, decompression, expansion of coronary artery wait symptomatic treatments, while adding and using oral solution of the present invention
20ml/ times, 3 times a day；Symptom is substantially reduced, and blood pressure stabilization is normal, and the aobvious amount of electrocardiogram degree of ischemia mitigates, under the aobvious amount of blood fat
Drop, significantly effectively reach clinical cure standard, the 23rd day check blood fat, total cholesterol 4.8mmol/L, triglyceride 1.5mmol/L,
Low-density albumen 3.21mmol/L, high-density protein 1.98mmol/L.It advises patient's low fat diet, moderate exercise to adhere to taking medicine, consolidates
Gu curative effect.
Finally it should be noted that：The above embodiments are merely illustrative of the technical solutions of the present invention, rather than its limitations；Although
Present invention has been described in detail with reference to the aforementioned embodiments, it will be understood by those of ordinary skill in the art that：It still may be used
With technical scheme described in the above embodiments is modified or equivalent replacement of some of the technical features；
And these modifications or replacements, various embodiments of the present invention technical solution that it does not separate the essence of the corresponding technical solution spirit and
Range.
Claims (4)
1. a kind of Chinese medicine preparation for treating fatty liver and hyperlipidemia, which is characterized in that its raw material is following Chinese medicinal component：
Curcuma zedoary, radix paeoniae rubra, hawthorn, gynostemma pentaphylla, Cassia occidentalis, giant knotweed, turmeric, Radix Astragali, matrimony vine；And the mass fraction of each traditional Chinese medicinal components is as follows：
15 parts -75 parts of curcuma zedoary, 12 parts -60 parts of radix paeoniae rubra, 12 parts -60 parts of hawthorn, 12 parts -60 parts of gynostemma pentaphylla, 12 part -60 of Cassia occidentalis
Part, 15 parts -75 parts of giant knotweed, 12 parts -60 parts of turmeric, 15 parts -75 parts of Radix Astragali, 15 parts -75 parts of matrimony vine.
2. the Chinese medicine preparation according to claim 1 for treating fatty liver and hyperlipidemia, which is characterized in that its raw material
For the traditional Chinese medicinal components of following mass parts：15 parts of curcuma zedoary, 12 parts of radix paeoniae rubra, 12 parts of hawthorn, 12 parts of gynostemma pentaphylla, 12 parts of Cassia occidentalis, giant knotweed
15 parts, 12 parts of turmeric, 15 parts of Radix Astragali, 15 parts of matrimony vine.
3. the Chinese medicine preparation according to claim 1 for treating fatty liver and hyperlipidemia, which is characterized in that its raw material
For the traditional Chinese medicinal components of following mass parts：30 parts of curcuma zedoary of selection, 24 parts of radix paeoniae rubra, 24 parts of hawthorn, 24 parts of gynostemma pentaphylla, 24 parts of Cassia occidentalis,
30 parts of giant knotweed, 24 parts of turmeric, 30 parts of Radix Astragali, 30 parts of matrimony vine.
4. the Chinese medicine preparation according to claim 1 for treating fatty liver and hyperlipidemia, which is characterized in that its raw material
For the traditional Chinese medicinal components of following mass parts：75 parts of curcuma zedoary of selection, 60 parts of radix paeoniae rubra, 60 parts of hawthorn, 60 parts of gynostemma pentaphylla, 60 parts of Cassia occidentalis,
75 parts of giant knotweed, 60 parts of turmeric, 75 parts of Radix Astragali, 75 parts of matrimony vine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410800220.2A CN104491725B (en) | 2014-12-18 | 2014-12-18 | A kind of Chinese medicine preparation for treating fatty liver and hyperlipidemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410800220.2A CN104491725B (en) | 2014-12-18 | 2014-12-18 | A kind of Chinese medicine preparation for treating fatty liver and hyperlipidemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104491725A CN104491725A (en) | 2015-04-08 |
| CN104491725B true CN104491725B (en) | 2018-09-28 |
Family
ID=52933239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410800220.2A Expired - Fee Related CN104491725B (en) | 2014-12-18 | 2014-12-18 | A kind of Chinese medicine preparation for treating fatty liver and hyperlipidemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104491725B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101244157A (en) * | 2007-02-15 | 2008-08-20 | 南京万舜源生物科技有限公司 | Natural plants extract, preparation method and application thereof |
| CN102423413A (en) * | 2012-01-04 | 2012-04-25 | 陈伯明 | Medicament for treating hyperlipemia and fatty liver and preventing atherosclerosis as well as applications thereof |
| CN103705854A (en) * | 2013-12-30 | 2014-04-09 | 郭兰春 | Semen cassiae, fructus lycii and glossy privet fruit oral solution with functions of tonifying liver and reducing fat |
-
2014
- 2014-12-18 CN CN201410800220.2A patent/CN104491725B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101244157A (en) * | 2007-02-15 | 2008-08-20 | 南京万舜源生物科技有限公司 | Natural plants extract, preparation method and application thereof |
| CN102423413A (en) * | 2012-01-04 | 2012-04-25 | 陈伯明 | Medicament for treating hyperlipemia and fatty liver and preventing atherosclerosis as well as applications thereof |
| CN103705854A (en) * | 2013-12-30 | 2014-04-09 | 郭兰春 | Semen cassiae, fructus lycii and glossy privet fruit oral solution with functions of tonifying liver and reducing fat |
Non-Patent Citations (1)
| Title |
|---|
| 140味降脂中药治疗高脂血症的用药规律分析;钟周等;《湖南中医药大学学报》;20150131;第35卷(第1期);第64-66页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104491725A (en) | 2015-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100443112C (en) | Medicine for treating gout and gout arthritis | |
| CN108524673A (en) | A kind of Chinese medicine composition and its application | |
| CN1814162A (en) | Pulse-promoting large-volume injecta and preparing method | |
| CN102048821A (en) | Method for preparing perhexiline pharmaceutical preparation | |
| CN106723048A (en) | One kind is for health food for relieving fatigue and preparation method thereof | |
| CN1718193A (en) | Total secondary ginseng glucoside medicine composition, its prepn. method and application in preparing medicine for treating myocardial ischemia and hemorrhagic shock | |
| CN104491725B (en) | A kind of Chinese medicine preparation for treating fatty liver and hyperlipidemia | |
| CN104524448B (en) | A kind of Chinese medicine preparation preparation method for treating fatty liver and hyperlipidemia | |
| CN104547261A (en) | Medicine for treating hyperlipidemia | |
| CN104587387B (en) | A kind of combined traditional Chinese medicine and preparation method for preventing and treating three high diseases | |
| CN105147944B (en) | A kind of Chinese medicine composition, its preparation and its preparation method and application | |
| CN104189314B (en) | It is a kind of to treat the turbid pharmaceutical composition for checking card high fat of blood of phlegm | |
| CN104524448A (en) | Preparation method of traditional Chinese medicine preparation for treating fatty liver and hyperlipidaemia | |
| CN102114185A (en) | Medicament for treating insulin resistance of type 2 diabetes | |
| CN103623103B (en) | Traditional Chinese medicine preparation for treating coughing and phlegmy throat | |
| CN106728828A (en) | A kind of Chinese medicine preparation and its preparation technology for treating coronary heart disease | |
| CN102526628B (en) | Medicinal composition for treating myocardial infarction | |
| CN106692873A (en) | Formula and preparation method of traditional Chinese medicine for treatimg hyperlipemia | |
| JPS5813518A (en) | Preparation of drug consisting of ganoderma lucidum and elfvingia applanata | |
| CN104873762A (en) | Gallnut traditional Chinese medicine preparation for treating diabetes and preparation method | |
| CN105560597A (en) | Medicine for treating hypotension | |
| CN106262818A (en) | A kind of blood sugar lowering oral liquid and preparation method thereof | |
| CN110680881A (en) | Traditional Chinese medicine for reducing blood pressure and preparation method thereof | |
| CN108236623A (en) | Pharmaceutical composition, traditional Chinese medicine oral liquid, Chinese herbal granules and its preparation method and application | |
| CN115400175A (en) | Traditional Chinese medicine composition for treating chronic renal failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Hao Shaojun Inventor after: Lu Wenxian Inventor after: Ma Junjie Inventor after: Lv Hongdi Inventor after: Li Jun Inventor after: Geng Xiuli Inventor after: Wang Xidong Inventor after: Wang Junqiong Inventor after: Zhang Zhengchen Inventor before: Hao Shaojun Inventor before: Lv Hongdi Inventor before: Li Jun Inventor before: Geng Xiuli Inventor before: Wang Xidong Inventor before: Wang Junqiong Inventor before: Zhang Zhengchen |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180928 Termination date: 20201218 |